Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Indivior Pharmaceuticals (NASDAQ:INDV) through any online brokerage.
Other companies in Indivior Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Indivior Pharmaceuticals has a consensus price target of $37.20.
The stock price for Indivior Pharmaceuticals (NASDAQ: INDV) is $35.83 last updated October 9, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Indivior Pharmaceuticals.
Indivior Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Indivior Pharmaceuticals.
Indivior Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.